Background: Ataxia Telangiectasia (A-T) is a rare neurodegenerative disorder that affects a number of different systems of the body. Aim of the work:To identify the spectrum of clinical presentations of children with A-T. Methods: Retrospective cohort study of data of 35 children with confirmed diagnosis of A-T. Results: A-T clinical spectrum was diverse with two distinct presentations according to age of onset of symptoms; classic early onset among 29 (82%) (mean age± SD= 2.9 ± 0.63 years) and variant late in 6 (17%) (mean age± SD=9.83 ± 1.34 years). In early onset A-T the leading presentations were classic; ataxia in 100%, telangiectasis (100%), dysarthria (62%), cerebellar atrophy (58%), repeated sinopulmonary infections (48%), autoimmune vitiligo in one child, but not peripheral neuropathy or postural scoliosis. While among those with late onset A-T, the leading presentations were extrapyramidal manifestations and dystonia in (66.6%), late development of ataxia (100%), telangiectasis (50%), dysarthria (66.6%), repeated sinopulmonary infections (16.6%), cerebellar atrophy (16.6%) and peripheral neuropathy (50%). All 35 (100%) had elevated alfa fetoprotein, 74% had reduced IgE levels and 68% had reduced IgA levels. Acute lymphoblastic leukemia (ALL) complicated the course of 17.2% and 16.6% of early and variant late onset A-T respectively, and preceded the onset of ataxia among 50% of affected cases. Conclusion: Ataxia telangiectasia is a rare neurologic disease with various clinical presentations. A-T clinical spectrum is diverse with two distinct presentations according to age of presentation: classic early onset and variant late onset. Immune dysregulation is more pronounced among the early onset group. ALL might be the initial presentation of A-T that precedes the onset of ataxia and of telangiectasis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.